GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Claritas Pharmaceuticals Inc (FRA:S6VA) » Definitions » Cash Flow from Discontinued Operations

Claritas Pharmaceuticals (FRA:S6VA) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Sep. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Claritas Pharmaceuticals Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Claritas Pharmaceuticals's cash flow from discontinued operations for the three months ended in Sep. 2021 was €0.00 Mil. It means Claritas Pharmaceuticals received €0.00 Mil from the sale of part of business quarterly. Claritas Pharmaceuticals's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2021 was €0.00 Mil.

Claritas Pharmaceuticals Cash Flow from Discontinued Operations Historical Data

The historical data trend for Claritas Pharmaceuticals's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritas Pharmaceuticals Cash Flow from Discontinued Operations Chart

Claritas Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Claritas Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Claritas Pharmaceuticals Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Claritas Pharmaceuticals Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Claritas Pharmaceuticals's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Claritas Pharmaceuticals (FRA:S6VA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Claritas Pharmaceuticals Inc (FRA:S6VA) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
HSTC RSPI GTHR ZSANQ QBIO RBSH RGIN GNCA ENDV HALB OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN ALNY
Traded in Other Exchanges
N/A
Address
4040 Civic Center Drive, Suite 200, San Rafael, CA, USA, 94903
Website
https://www.claritaspharma.com
Claritas Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company developing a portfolio of pharmaceutical products in Canada. It develops new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing, and delivering human therapeutics.

Claritas Pharmaceuticals (FRA:S6VA) Headlines

No Headlines